Oxiquim Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Oxiquim.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Chemicals earnings growth | 69.4% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Oxiquim's (SNSE:OXIQUIM) Shareholders May Want To Dig Deeper Than Statutory Profit
Apr 07Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?
Jun 10Are Dividend Investors Making A Mistake With Oxiquim S.A. (SNSE:OXIQUIM)?
Apr 22Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down
Apr 01Oxiquim S.A.'s (SNSE:OXIQUIM) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Mar 11Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?
Feb 18Did You Participate In Any Of Oxiquim's (SNSE:OXIQUIM) Incredible 355% Return?
Jan 27Has Oxiquim (SNSE:OXIQUIM) Got What It Takes To Become A Multi-Bagger?
Dec 28Oxiquim S.A. (SNSE:OXIQUIM) On An Uptrend: Could Fundamentals Be Driving The Stock?
Dec 07In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Oxiquim has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 214,649 | 23,896 | 27,739 | 40,573 | N/A |
9/30/2023 | 221,904 | 24,930 | 28,077 | 42,743 | N/A |
6/30/2023 | 243,733 | 27,088 | 22,016 | 36,393 | N/A |
3/31/2023 | 258,547 | 27,220 | 8,425 | 23,340 | N/A |
12/31/2022 | 264,695 | 29,252 | 3,446 | 15,979 | N/A |
9/30/2022 | 262,663 | 28,624 | 7,175 | 19,119 | N/A |
6/30/2022 | 238,874 | 25,710 | 1,578 | 11,795 | N/A |
3/31/2022 | 213,134 | 24,850 | 9,036 | 19,582 | N/A |
12/31/2021 | 191,128 | 20,727 | 10,523 | 21,859 | N/A |
9/30/2021 | 170,947 | 18,471 | 7,701 | 23,493 | N/A |
6/30/2021 | 161,252 | 18,276 | 11,142 | 30,618 | N/A |
3/31/2021 | 155,708 | 16,972 | 11,105 | 30,697 | N/A |
12/31/2020 | 158,135 | 17,219 | 11,656 | 33,299 | N/A |
9/30/2020 | 158,113 | 16,720 | 6,499 | 28,481 | N/A |
6/30/2020 | 155,569 | 15,368 | 2,271 | 22,177 | N/A |
3/31/2020 | 155,075 | 15,874 | 11,003 | 28,813 | N/A |
12/31/2019 | 152,021 | 15,618 | 12,255 | 27,042 | N/A |
9/30/2019 | 154,655 | 14,770 | 10,891 | 20,820 | N/A |
6/30/2019 | 157,881 | 16,018 | 18,888 | 28,597 | N/A |
3/31/2019 | 158,870 | 15,263 | 6,889 | 16,451 | N/A |
12/31/2018 | 156,502 | 14,302 | 9,405 | 18,635 | N/A |
9/30/2018 | 151,351 | 13,534 | 14,705 | 21,781 | N/A |
6/30/2018 | 146,847 | 12,685 | 12,304 | 17,028 | N/A |
3/31/2018 | 145,208 | 18,055 | 25,765 | 29,839 | N/A |
12/31/2017 | 144,253 | 18,294 | 22,538 | 25,760 | N/A |
9/30/2017 | 141,722 | 21,842 | N/A | 24,332 | N/A |
6/30/2017 | 138,877 | 21,562 | N/A | 24,845 | N/A |
3/31/2017 | 135,566 | 16,033 | N/A | 22,466 | N/A |
12/31/2016 | 134,438 | 16,492 | N/A | 23,811 | N/A |
9/30/2016 | 136,729 | 13,242 | N/A | 26,257 | N/A |
6/30/2016 | 140,238 | 13,054 | N/A | 23,287 | N/A |
3/31/2016 | 142,591 | 12,493 | N/A | 23,350 | N/A |
12/31/2015 | 144,059 | 12,013 | N/A | 21,237 | N/A |
9/30/2015 | 144,708 | 10,554 | N/A | 28,647 | N/A |
6/30/2015 | 142,750 | 9,386 | N/A | 26,275 | N/A |
3/31/2015 | 140,734 | 9,598 | N/A | 17,258 | N/A |
12/31/2014 | 140,119 | 8,592 | N/A | 21,385 | N/A |
9/30/2014 | 128,174 | 8,715 | N/A | -4,186 | N/A |
6/30/2014 | 129,377 | 7,667 | N/A | 4,921 | N/A |
3/31/2014 | 134,570 | 6,195 | N/A | 6,617 | N/A |
12/31/2013 | 133,314 | 5,392 | N/A | -562 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if OXIQUIM's forecast earnings growth is above the savings rate (5.4%).
Earnings vs Market: Insufficient data to determine if OXIQUIM's earnings are forecast to grow faster than the CL market
High Growth Earnings: Insufficient data to determine if OXIQUIM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if OXIQUIM's revenue is forecast to grow faster than the CL market.
High Growth Revenue: Insufficient data to determine if OXIQUIM's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OXIQUIM's Return on Equity is forecast to be high in 3 years time